MacroGenics to Participate in Upcoming Investor Conferences

ROCKVILLE, MD, Nov. 05, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that the Company’s management team will participate in the following investor conferences in November: * Stifel 2026 Healthcare Conference (New York, NY). MacroGenics’ President and CEO, Eric Risser, will participate in a fireside chat on Wednesday, November 11, at 10:00 am ET. MacroGenics’ management will also participate in one-on-one meetings. * 9th Annual Evercore Healthcare Conference (Coral Gables, FL). Mr. Risser will participate in a fireside chat on Monday, November 30, at 3:00 pm ET. MacroGenics’ management will also participate in one-on-one meetings. Webcasts of these presentations may be accessed under "Events & Presentations" in the Investor Relations section of MacroGenics' website at http://ir.macrogenics.com/events.cfm. The Company will maintain archived replays of the webcasts on its website for 30 days.